𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Early Clinical Data with Small-Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitors

✍ Scribed by G. Kesava Reddy; Sakkaraiappan Ramalingam; Vinay K. Jain

Book ID
114411903
Publisher
CIG Media Group, LP.
Year
2004
Tongue
English
Weight
83 KB
Volume
6
Category
Article
ISSN
1525-7304

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II study of SU5416β€”a small-molecul
Phase II study of SU5416β€”a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitorβ€”in patients with refractory myeloproliferative diseases
✍ Francis J. Giles; Maureen A. Cooper; Lewis Silverman; Judith E. Karp; Jeffrey E. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

## Abstract ## BACKGROUND Increased bone marrow angiogenesis and vascular endothelial growth factor (VEGF) levels are of adverse prognostic significance in patients with myeloproliferative disorders (MPD), including agnogenic myeloid metaplasia (AMM), chronic myeloid leukemia in blastic phase (CML